
|Articles|July 1, 2003
Santen seeks OK for concentrated antibiotic
Napa, CA-Santen Pharmaceutical Co. is hoping that its higher-concentration ocular antibiotic will set a new standard for treatment of bacterial corneal ulcers.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Closing the gap: John Berdahl, MD, on the global cataract burden and the emerging dementia connection
2
FDA guidance to help accelerate cell and gene therapies
3
Oculis phase 3 DIAMOND trials miss vision endpoints in diabetic macular edema
4
The Residency Report: Cardiovascular risk scores as a window into ocular disease
5





















